Canakinumab in Patients With COVID-19 and Type 2 Diabetes (2020)
Backhttps://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602a179cf8ebc41559499af_Unispital.jpg
https://clinicaltrials.gov/study/NCT04510493
https://uploads-ssl.webflow.com/65dc93ef0a9b2f3705d0635e/6602a179cf8ebc41559499af_Unispital.jpg
https://clinicaltrials.gov/study/NCT04510493